Out of the Shadow (2004 film)

Last updated
Out of the Shadow
Out of the Shadow 2004 film DVD cover.jpg
Directed bySusan Smiley
Release date
  • 2004 (2004)
Running time
67 minutes
CountryUnited States

Out of the Shadow is a grassroots documentary film by Susan Smiley concerning her mother, Mildred Smiley. Mildred Smiley is a middle-aged woman who has battled schizophrenia for over twenty years. The documentary chronicles her journey from psychiatric wards, nursing and group homes in Illinois, United States. [1]

Out of the Shadow is composed of interview footage interspersed with home movies and photographs. [2]

The film has been positively reviewed by mental health journals such as Clinical Psychiatry News and the Journal of Medical Humanities . [3]

Related Research Articles

Antipsychotic Class of medications

Antipsychotics, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay together with mood stabilizers in the treatment of bipolar disorder.

Psychosis Abnormal condition of the mind

Psychosis is a condition of the mind that results in difficulties determining what is real and what is not real. Symptoms may include delusions and hallucinations, among other features. Additional symptoms are incoherent speech and behavior that is inappropriate for a given situation. There may also be sleep problems, social withdrawal, lack of motivation, and difficulties carrying out daily activities. Psychosis can have serious adverse outcomes.

Schizophrenia Mental disorder characterized by psychosis

Schizophrenia is a mental disorder characterized by continuous or relapsing episodes of psychosis. Major symptoms include hallucinations, delusions, paranoia, and disorganized thinking. Other symptoms include social withdrawal, decreased emotional expression, and apathy. Symptoms typically come on gradually, begin in young adulthood, and in many cases never resolve. There is no objective diagnostic test; the diagnosis is used to describe observed behavior that may stem from numerous different causes. Besides observed behavior, doctors will also take a history that includes the person's reported experiences, and reports of others familiar with the person, when making a diagnosis. To diagnose someone with schizophrenia, doctors are supposed to confirm that symptoms and functional impairment are present for six months (DSM-5) or one month (ICD-11). Many people with schizophrenia have other mental disorders, especially substance use disorders, depressive disorders, anxiety disorders, and obsessive–compulsive disorder.

Clozapine Atypical antipsychotic medication

Clozapine is a psychiatric medication and is the first atypical antipsychotic. It is primarily used to treat people with schizophrenia and schizoaffective disorders who have had an inadequate response to other antipsychotics or who have been unable to tolerate other drugs due to extrapyramidal side effects. It is also used for the treatment of psychosis in Parkinson's disease. Clozapine is regarded as the gold-standard treatment when other medication has been insufficiently effective and its use is recommended by multiple international treatment guidelines, after resistance to earlier neuroleptic treatment is established.

Schizoaffective disorder is a mental disorder characterized by abnormal thought processes and an unstable mood. This diagnosis is made when the person has symptoms of both schizophrenia and a mood disorder: either bipolar disorder or depression. The main criterion for a diagnosis of schizoaffective disorder is the presence of psychotic symptoms for at least two weeks without any mood symptoms present. Schizoaffective disorder can often be misdiagnosed when the correct diagnosis may be psychotic depression, bipolar I disorder, schizophreniform disorder, or schizophrenia. It is imperative for providers to accurately diagnose patients, as treatment and prognosis differ greatly for each of these diagnoses.

Richard Bentall is a Professor of Clinical Psychology at the University of Sheffield in the UK.

In psychology, alogia is poor thinking inferred from speech and language usage. There may be a general lack of additional, unprompted content seen in normal speech, so replies to questions may be brief and concrete, with less spontaneous speech. This is termed poverty of speech or laconic speech. The amount of speech may be normal but conveys little information because it is vague, empty, stereotyped, overconcrete, overabstract, or repetitive. This is termed poverty of content or poverty of content of speech. Under Scale for the Assessment of Negative Symptoms used in clinical research, thought blocking is considered a part of alogia, and so is increased latency in response.

Biological psychiatry or biopsychiatry is an approach to psychiatry that aims to understand mental disorder in terms of the biological function of the nervous system. It is interdisciplinary in its approach and draws on sciences such as neuroscience, psychopharmacology, biochemistry, genetics, epigenetics and physiology to investigate the biological bases of behavior and psychopathology. Biopsychiatry is the branch of medicine which deals with the study of the biological function of the nervous system in mental disorders.

Orthomolecular psychiatry is the use of orthomolecular medicine for mental illness. The approach uses unorthodox forms of individualized testing and diagnosis to attempt to establish an etiology for each patient's specific symptoms, and claims to tailor the treatment accordingly, using a combination of nutrients, dietary changes and medications that are claimed to enhance quality of life and functionality as well as to reduce or eliminate symptoms and the use of xenobiotic drugs. Scientific studies have shown the orthomolecular psychiatry is ineffective. Orthomolecular psychiatry has been rejected by the mainstream medical community.

Insulin shock therapy Psychiatric treatment

Insulin shock therapy or insulin coma therapy was a form of psychiatric treatment in which patients were repeatedly injected with large doses of insulin in order to produce daily comas over several weeks. It was introduced in 1927 by Austrian-American psychiatrist Manfred Sakel and used extensively in the 1940s and 1950s, mainly for schizophrenia, before falling out of favour and being replaced by neuroleptic drugs in the 1960s.

The trauma model of mental disorders, or trauma model of psychopathology, emphasises the effects of physical, sexual and psychological trauma as key causal factors in the development of psychiatric disorders, including depression and anxiety as well as psychosis, whether the trauma is experienced in childhood or adulthood. It conceptualises victims as having understandable reactions to traumatic events rather than suffering from mental illness.

Clinical vampirism, more commonly known as Renfield's syndrome, is an obsession with drinking blood. The earliest presentation of clinical vampirism in psychiatric literature was a psychoanalytic interpretation of two cases, contributed by Richard L. Vanden Bergh and John. F. Kelley. As the authors point out, over 50,000 people addicted to drinking blood have appeared in the psychiatric literature from 1892 to 2010. This was documented in the work of Austrian forensic psychiatrist Richard von Krafft-Ebing. Many medical publications concerning clinical vampirism can be found in the literature of forensic psychiatry, with the behavior being reported as an aspect of extraordinary violent crimes.

Loren Richard Mosher was an American psychiatrist, clinical professor of psychiatry, expert on schizophrenia and the chief of the Center for Studies of Schizophrenia in the National Institute of Mental Health (1968–1980). Mosher spent his professional career advocating for humane and effective treatment for people diagnosed as having schizophrenia and was instrumental in developing an innovative, residential, home-like, non-hospital, non-drug treatment model for newly identified acutely psychotic persons.

Jeffrey Lieberman American psychiatrist (born 1948)

Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia. He was president of the American Psychiatric Association from May 2013 to May 2014.

The diagnosis of schizophrenia, a psychotic disorder, is based on criteria in either the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, or the World Health Organization's International Classification of Diseases (ICD). Clinical assessment of schizophrenia is carried out by a mental health professional based on observed behavior, reported experiences, and reports of others familiar with the person. Diagnosis is usually made by a psychiatrist. Associated symptoms occur along a continuum in the population and must reach a certain severity and level of impairment before a diagnosis is made. Schizophrenia has a prevalence rate of 0.3-0.7% in the United States

Out of the Shadow may refer to:

Colin A. Ross is a Canadian psychiatrist and former president of the International Society for the Study of Trauma and Dissociation from 1993 to 1994. There is controversy about his methods and claims, which include recovering memories through hypnosis of Satanic ritual abuse and his own assertion that he can harness chi energy from his eyes to manipulate electronics.

Psychiatry is, and has historically been, viewed as controversial by those under its care, as well as sociologists and psychiatrists themselves. There are a variety of reasons cited for this controversy, including the subjectivity of diagnosis, the use of diagnosis and treatment for social and political control including detaining citizens and treating them without consent, the side effects of treatments such as electroconvulsive therapy, antipsychotics and historical procedures like the lobotomy and other forms of psychosurgery or insulin shock therapy, and the history of racism within the profession in the United States.

Michael A. Schwartz American academic and psychiatrist

Michael Alan Schwartz is an American academic and psychiatrist based in Austin, Texas. In 2018 Schwartz retired as Clinical Professor of Psychiatry and Joint Professor of Humanities in Medicine at the Texas A&M School of Medicine. He is currently and Adjunct Professor at this medical school. His work has focused on advancing pluralistic, person and people-centered approaches to psychiatric assessment, care and treatment.

Thara Rangaswamy Indian psychiatrist and schizophreniz researcher

Thara Rangaswamy is a psychiatrist in India, the co-founder of an NGO called SCARF based in Chennai, India. She is a researcher in schizophrenia and community mental health. In 2020, she received the SIRS Outstanding Clinical and Community Research Award of SIRS, an apex body for work on schizophrenia in Florence, Italy.

References

  1. Stewart, Susan (2006-10-07). "Out of the Shadow - TV - Review". The New York Times. ISSN   0362-4331 . Retrieved 2017-12-08.
  2. "All about My Mother" by Atkinson, Roland - Clinical Psychiatry News, Vol. 33, Issue 5, May 2005".[ dead link ]
  3. Diedrich, Lisa (1 June 2010). "Being the Shadow: Witnessing Schizophrenia". Journal of Medical Humanities. 31 (2): 91–109. doi:10.1007/s10912-010-9109-1. PMID   20127152. S2CID   6543548.